符合肿瘤和血液医学咨询团队

Covance has a dedicated team of over 50 oncology physicians with an average of 23 years of industry and clinical experience, in countries across Europe, North America, Latin America and Asia. Covance physicians’ experience extend from translational/early phase development through product launch, late-phase/post marketing studies. Our medical team has been carefully selected based upon clinical, academic, and industry experience that cover the majority of oncology indications including pediatric oncology.

在这个肿瘤医疗团队是一个专业team of Oncology medical consultants. This team provides expertise in life-cycle management of specific tumor indications including clinical development planning and strategy, establishment of target product profiles, program feasibility, risk assessment, and execution, registries, as well as program- and study-level medical oversight. They will share their collective expertise with you throughout your entire clinical journey to help you bring crucial treatments safely and efficiently to oncology patients.


Meet the Team

Ariel E. Aguiló, MD
Senior Medical Director

Ariel Aguiló, MD, Senior Medical Director for Covance Clinical Development Services in Buenos Aires, Argentina, is a board-certified oncologist specialized in gastrointestinal tumors. He provides subject matter expertise and support for the development and conduct of clinical trials on clients’ drug development projects, including serving as the company’s subject matter expert for Decentralized Clinical Trials (DCT). Dr. Aguiló performs medical monitoring on assigned projects, contributes to the medical strategy and execution of clinical programs, and brings scientific strategic leadership to the Oncology area at Covance. He has 10 years of experience as a physician, medical advisor and medical director in drug research and development. Before joining Covance, he served as Medical Director for Syneos Health in Buenos Aires, and prior to that, served as Medical Advisor for IQVIA in Buenos Aires. Dr. Aguiló began his career as Attending Physician, GI Oncology Department, Hospital de Gastroenterologia. He joined Covance in November 2019.

Ariel E. Aguiló, MD Senior Medical Director

Maria Ignacia Berraondo, MD
Senior Medical Director

Maria Ignacia Berraondo,MD,是凯悦临床开发服务高级医疗总监,位于阿根廷布宜诺斯艾利斯。她为项目团队和其他董事会部门提供临床和医学专业知识,以推进客户的药物发展计划。Berraondo博士在指定的项目中执行医疗和安全监控;制定和评论议定书,案例报告表格和其他数据和材料,并有助于Covance的肿瘤学领域的科学战略领导。Berraondo博士在血液学和医疗顾问和医生中拥有超过10年的经验,临床研究六年,包括作为临床研发的董事。在加入Covance之前,她在布宜诺斯艾利斯的IQVIA担任医疗总监。Berraondo博士于2020年7月加入了Covance。

Maria Ignacia Berraondo, MD

Stefanella Bortini, PhD, MD
Senior Medical Director

斯特凡耳博多蒂尼,博士,博士,是在意大利米兰的米兰临床开发服务的高级医疗主任,肿瘤学院。她有助于制定涉及医疗,安全和治疗性的密切政策,并在指定的项目中作为全球领导项目医生。Bortini博士将在临床研究中带来30多年的临床研究经验。在加入公司之前,她是米兰的Chiltern International的高级主任,医学,肿瘤学。她还担任I3研究,PRA International,Pharmacia&Upjohn和Eli Lilly的职位。Bortini博士是由意大利医疗和外科医疗委员会的医学委员会授权,并为美国举行了ECFMG医疗认证,她收到了意大利佛罗伦省大学的医疗学位,以及来自西北大学的生物医学工程博士学位。她于2019年7月加入了Covance。

Stefanella Bortini, PhD, MD Senior Medical Director

Jose Daniel Fanjul Fuente, MD
Medical Director

Jose Daniel Fanjul Fuente, MD, is Medical Director, Oncology, for Covance Clinical Development Services, based in Madrid, Spain. He provides medical and scientific guidance and support to project teams and investigative sites on clients’ drug development projects, and reviews protocols, case report forms, clinical study reports and other data and materials. Dr. Fuente has more than 10 years of experience as a physician and medical director in clinical research and development specializing in oncology. Before his current position, he held medical director and manager positions in oncology with IQVIA and Bristol Myers Squibb in Buenos Aires, Argentina. At Bristol Myers Squibb, Dr. Fuente led scientific activities that gave impetus to the product line of the oncology therapeutic area (NivolumabandIpilimumab). He joined Covance in October 2018.

Begoña de las Heras Garcia, MD
Senior Medical Director

Begoña de las Heras Garcia, MD, is Senior Medical Director, Oncology, for Covance Clinical Development Services, based in Madrid, Spain. She is board certified Medical Oncologist, by La Paz hospital, Madrid, Spain. Begoña joined Covance in 2016. She serves as project physician on clients’ drug development projects and provides medical/scientific expertise to project teams/business development teams. Also, she has line management activities of a group of MDs in the Oncology TA. She brings more than 20 years of national and international clinical oncology research experience to Covance. Before her current position, she served as Executive Medical Officer, Early Phase, for Chiltern in the UK. She also has held clinical research positions with Eisai in the UK and a several organizations in Spain including Pivotal CRO, Pharma Mar, AstraZeneca and Bristol-Myers Squibb. She also, was oncologist consult in several hospitals in Spain, General Yagüe Hospital in Burgos, Ntra Sra. Del Prado Hospital in Talavera de la Reina (Toledo) and La Paz Hospital in Madrid.

Begoña de las Heras, MD Senior Medical Director

Brian Hamilton, MD, PhD
Senior Medical Director

Brian Hamilton, MD, PhD, is Senior Medical Director for Covance Clinical Development Services, based in Newton, Massachusetts. He serves as Covance Subject Matter Expert for cellular immune-oncology, CAR-T and gene therapy. He also serves as global lead project physician on clients’ drug development projects. Dr. Hamilton has more than 35 years of experience in pediatric medicine, immunology, hematopoietic stem cell transplantation, and clinical research and development. Before joining Covance, he served as Executive Medical Monitor for Chiltern International. He has also held senior-level medical director, director physician, regulatory affairs and clinical research positions with Galena Biopharma, AstraZeneca, Onyx Pharmaceuticals, Wyeth Oncology, and other pharmaceutical and biotech firms. Dr. Hamilton joined Covance in August 2018.

Brian Hamilton, MD, PhD

Konstantin Haradinov, MD
Medical Director

Konstantin Haradinov,MD,是医生肿瘤学,肿瘤学基于保加利亚索非亚的审计开发服务。他有助于发展涉及医疗,安全和治疗的愿望政策;作为全球领导项目医生,并提供指定项目的医疗和安全监测;评论医疗数据,为项目团队和其他景区部门提供临床和医学专业知识,并进行安全趋势分析。Haradinov博士在医疗总监和医生/肿瘤学家中有超过15年的临床研究经验。在加入Covance之前,他担任保加利亚索菲亚的Chiltern International的医务官员,肿瘤学。Haradinov博士于2019年4月加入了Covance。

He Huang, MD
Senior Medical Director

He Huang is Senior Director, Asia Pacific (APAC) for Covance Clinical Development Services, based in Shanghai, China. He brings more than 10 years of experience as a physician and researcher in oncology, respiratory therapy and drug development to Covance. Before joining Covance, He served as Disease Area Head, Oncology/GI, for Bristol-Myers Squibb in Shanghai. He also served as Senior Manager, Respiratory, for AstraZeneca, and Medical Manager, Oncology/GI, for Roche, in Shanghai. He received the Global Champion and China CEO award at AstraZeneca. He began career as Medical Oncologist at Affiliated Hospital of Tongji Medical College of Huazhong University of Science and Technology in Wuhan, China. He joined Covance in September 2019.

He Huang, MD Senior Medical Director

广告rianne Kelly, MD
Senior Medical Director

广告rianne Kelly, MD, is a Contracted Senior Medical Director for Covance Clinical Development Services, based in Princeton, New Jersey, and Chief Medical Officer of Jude, Peregrine and Kelly Consultants, LLC, in Bethesda, Maryland. She serves as lead project physician on clients’ drug development projects. Dr. Kelly provides medical/scientific feedback on protocols and clinical development plans, input on site feasibility relative to protocol requirements, medical monitoring on assigned projects, and training to project teams. She has more than 30 years of experience as a physician, clinical researcher and drug developer focused on hematology/oncology. Dr. Kelly earned her medical degree from Georgetown University and has received more than a dozen awards for leadership in healthcare and academic achievement. Dr. Kelly joined Covance in August 2010.

Geoffrey Kannan, PhD, MD
Senior Medical Director

Geoffrey Kannan, PhD, MD, is a Senior Medical Director in the Oncology Therapeutic Area for Covance Clinical Development Services, based in Princeton, New Jersey. Dr. Kannan serves as global lead project physician on clients’ drug development projects, providing medical expertise and support in the development and conduct of clinical trials. Dr. Kannan brings more than 10 years of experience as a physician and medical director to Covance, specializing in oncology and pediatrics. Before joining Covance, he practiced as Pediatric Hematologist/Oncologist and Pediatric Neuro-oncologist, affiliated with Children’s National Medical Center. Prior to that, he served as Instructor of Pediatrics and Pediatric Neuro-oncologist for the Department of Pediatric Neuro-oncology, Dana-Farber Cancer Institute/Boston Children’s Hospital/Harvard Medical School. The author or co-author of many peer-reviewed journal articles, presentations and abstracts, Dr. Kannan joined Covance in November 2018.

Geoffrey Kannan, PhD, MD

Carlo Lanza, MD, PhD
Executive Medical Officer

Carlo Lanza, MD, PhD, is Executive Medical Officer for Covance Clinical Development Services, based in Lugano, Switzerland. Dr. Lanza performs medical monitoring and safety assessments on Phase 1-4 clinical trials for Covance clients. He leads early phase and translational research early development programs with targeted therapies, small molecules, biologics and gene therapy. Dr. Lanza also oversees development of late-stage development strategies, delivery and approval of registrational programs. He brings more than 20 years of experience in clinical research and development as a physician and medical director, specializing in pediatrics and oncology. Before joining Covance, he served as Medical Director for Medicines for Malaria Venture in Geneva, Switzerland. Dr. Lanza has also held leadership positions with Novartis Oncology, Pfizer Global R&D, and AstraZeneca UK. Carlo joined Covance in 2012.

Carlo Lanza, MD, PhD, MSc Executive Medical Officer

Wojciech Massalski, MD
Medical Director

Wojciech Massalski博士是医学主任有限公司vance Clinical Development Services, based in Maidenhead, United Kingdom. He serves as global lead project physician on client projects, providing medical expertise and support in the development and conduct of clinical trials. This includes reviewing feasibility of investigator sites and recruitment of trial subjects and performing feasibility risk assessment and data safety monitoring on assigned projects. Dr. Massalski has more than 20 years of experience as a physician, clinical researcher and medical director. Before Covance, he was Senior Medical Officer for Chiltern International in the UK. He also has held clinical research and medical monitoring positions with Pfizer and Synexus Limited in the UK. Dr. Massalski joined Covance in April 2019.

Maria Mateo, MD
Senior Medical Director

Maria Mateo,MD,是凯悦临床开发服务高级医疗总监,位于阿根廷布宜诺斯艾利斯。她为项目团队和其他董事会部门提供临床和医学专业知识,以推进客户的药物发展计划。Mateo博士对指定的项目执行医疗和安全监测;制定和评论议定书,案例报告表格和其他数据和材料,并有助于Covance的肿瘤学领域的科学战略领导。Mateo博士拥有30多年的医生,临床研究员和医疗总监经验,以前持有Amgen,Boehringer-Ingelheim,Iqvia,Ivax阿根廷,Syneos健康,Bristol-Myers Squibb等药物开发和医疗保健的职位组织。Mateo博士于2020年11月加入了Covance。

Maria Mateo, MD

瓦莱里·诺维科夫先生,医学博士
Senior Medical Director

瓦莱里·诺维科夫先生,医学博士, is Senior Medical Director for Covance Clinical Development Services, based in Paris, France. She is responsible for the medical strategy and execution of clients’ clinical research projects. Dr. Novikov reviews protocols, case report forms, clinical trial reports, new drug applications, laboratory values, adverse events, data tables and other data and materials. She also is responsible for medical and safety monitoring on assigned projects. She brings more than 20 years of national and international clinical research experience to Covance. Before joining Covance, Dr. Novikov served as Clinical Study Director for Sanofi in France. He has also held clinical research positions with Generium, Helios Clinical Research, and PRA International in Moscow, Russia. Dr. Novikov joined Covance in August 2019.

Martine Poelman, MD
Executive Medical Director

Martine Poelman is Executive Medical Director, Oncology, for Covance Clinical Development Services, based in Brussels, Belgium. She provides medical and scientific support to help advance drug development in hematological malignancies for Covance clients. Martine brings more than 30 years of experience in clinical research and development as a physician and medical director, specializing in pediatrics and oncology, to Covance. Before assuming her current position, Martine served more than 15 years as Global Head of Oncology Research for Covance, providing medical monitoring for more than 200 clinical trials. Before joining Covance, she served as Clinical Research Physician, Hemato-Oncology-Infectiology, for Eli Lilly in Brussels. Before going into research, she served as Bone Marrow Transplantation and Hemato-Oncology Physician for the Department of Pediatric Oncology, Wilhelmina Children’s Hospital, in The Netherlands. Martine joined Covance in November 1996.

Martine-Poelman-WEB

Chia Portera, MD, PhD
Senior Medical Director

Chia Porterera,博士,博士,普林斯顿普林斯顿的凯悦临床开发服务高级医疗总监。她评估并建立了客户临床研究项目的药物发展战略,为项目团队提供科学/临床专业知识。波特拉博士开发,审查和修订协议,临床​​试验报告,新药物和其他数据和文件,负责对指定项目的医疗和安全监测。她在临床研发中拥有超过10年的医疗肿瘤科医生和医疗总监经验。作为Genentech的医务总监,在加入Covance之前,Portera博士LED后市场疗法的临床发展策略,用于治疗HER2 +乳腺癌。她于2015年7月加入了景点。

Chia Portera, MD, PhD

Kamal Veer Singh Saini, MD
Executive Medical Director

Kamal Veer Singh Saini, MD, is Executive Medical Director, Oncology, for Covance Clinical Development Services, based in Brussels, Belgium. Kamal is a board-certified medical oncologist, with an active license to practice in the UK. He contributes to the scientific strategic leadership of the Oncology area at Covance, and provides clinical and medical expertise to project teams and other Covance departments on clients’ drug development projects. Kamal brings more than 15 years of experience in clinical research and development to Covance. He previously served as Associate Scientific Director for an academic research organization and as Medical Advisor, Institute Jules Bordet, Brussels. The author or co-author of several peer-reviewed journal articles, Kamal joined Covance in June 2015.

Kamal Veer Saini

Chiara Sguotti, MD
Senior Medical Director

Chiara Sguotti, MD, is Senior Medical Director for Covance Clinical Development Services, based in Milano, Italy. She is responsible for all medical activities related to clients’ drug development projects. Dr. Sguotti provides medical expertise to project teams, reviews protocols and other data and materials, and provides medical and safety monitoring on assigned projects. She has more than 20 years of clinical development and medical affairs experience implementing and managing phase I to III solid tumor trials and has been involved in developing different classes of agents such as chemotherapeutic, endocrine, biological, and immune compounds. Before joining Covance, Dr. Sguotti held senior positions with Merck Seronno and Novartis AG in Switzerland, and Sanofi-Aventis, Pharmacia and Upjohn, and Sandoz in Italy. She joined Covance in January 2013.

Ivana Teodorovic, MD
Senior Medical Director

Ivana Teodorovic, MD, is Senior Medical Director for Covance Clinical Development Services, based in Brussels, Belgium. Dr. Teodorovic serves as project physician and provides scientific support on global and regional oncology studies for Covance clients. She develops, reviews and revises protocols, and coordinates and performs medical monitoring and review of patient data. Dr. Teodorovic brings more than 30 years of experience as a physician and medical director in drug research and development. Before joining Covance, she served more than 10 years as Coordinating Physician for the European Organization for Research and Treatment of Cancer Data Center Company (EORTC) in Brussels, where she authored the SOP-EORTC Tissue Research Policy. Dr. Teodorovic began her career as a certified anatomopathologist at the Institute for Oncology and Radiology in Belgrade, Serbia. She joined Covance in May 2005.

Ivana Teodorovic, MD Senior Medical Director

Laura Vidal, MD
Executive Medical Director

劳拉·维达尔博士是执行医疗主任Covance Clinical Development Services, based in Madrid, Spain. Dr. Vidal is the Medical Head of the Oncology group in EU. She contributes to the development of Covance policies involving medical, safety and therapeutics; serves as point of contact for key clients on business oversight; manages relationships with investigators/sites for clinical trials, and mentors clinical research physicians and medical directors across the company. Dr. Vidal has more than 15 years of experience as a physician, clinical oncologist, and medical director. Before joining Covance, she was Executive Medical Director for Syneos Health in Madrid, and previously served as a physician, medical oncologist, and clinical trials coordinator for a hospital in Barcelona. Dr. Vidal has authored or co-authored dozens of peer-reviewed journal articles and received numerous health and research awards. She joined Covance in December 2020.

Laura Vidal, MD